ProShare Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $252M | Sell |
1,811,223
-406,067
| -18% | -$56.9M | 0.37% | 31 |
|
|
2025
Q4 | $272M | Buy |
2,217,290
+623,752
| +39% | +$75.8M | 0.48% | 35 |
|
|
2025
Q3 | $177M | Sell |
1,593,538
-352,428
| -18% | -$40.1M | 0.37% | 72 |
|
|
2025
Q2 | $216M | Buy |
1,945,966
+93,083
| +5% | +$9.91M | 0.43% | 44 |
|
|
2025
Q1 | $208M | Buy |
1,852,883
+206,185
| +13% | +$21.3M | 0.47% | 47 |
|
|
2024
Q4 | $152M | Buy |
1,646,698
+224,825
| +16% | +$20.2M | 0.35% | 95 |
|
|
2024
Q3 | $119M | Buy |
1,421,873
+75,206
| +6% | +$5.74M | 0.29% | 103 |
|
|
2024
Q2 | $92.4M | Sell |
1,346,667
-134,320
| -9% | -$8.96M | 0.25% | 106 |
|
|
2024
Q1 | $108M | Buy |
1,480,987
+263,645
| +22% | +$20.3M | 0.29% | 104 |
|
|
2023
Q4 | $98.6M | Sell |
1,217,342
-213,934
| -15% | -$16.6M | 0.3% | 101 |
|
|
2023
Q3 | $107M | Buy |
1,431,276
+165,000
| +13% | +$12.7M | 0.33% | 98 |
|
|
2023
Q2 | $97.6M | Sell |
1,266,276
-64,995
| -5% | -$5.18M | 0.28% | 97 |
|
|
2023
Q1 | $110M | Buy |
1,331,271
+111,328
| +9% | +$9.22M | 0.34% | 95 |
|
|
2022
Q4 | $105M | Sell |
1,219,943
-160,923
| -12% | -$12.7M | 0.37% | 88 |
|
|
2022
Q3 | $85.2M | Sell |
1,380,866
-250,845
| -15% | -$15.8M | 0.33% | 92 |
|
|
2022
Q2 | $101M | Sell |
1,631,711
-796,722
| -33% | -$49.3M | 0.33% | 93 |
|
|
2022
Q1 | $144M | Sell |
2,428,433
-126,666
| -5% | -$8.1M | 0.31% | 94 |
|
|
2021
Q4 | $186M | Buy |
2,555,099
+768,758
| +43% | +$52.9M | 0.36% | 54 |
|
|
2021
Q3 | $125M | Buy |
1,786,341
+169,819
| +11% | +$11.9M | 0.35% | 92 |
|
|
2021
Q2 | $111M | Sell |
1,616,522
-20,008
| -1% | -$1.34M | 0.33% | 100 |
|
|
2021
Q1 | $106M | Buy |
1,636,530
+220,876
| +16% | +$14.2M | 0.33% | 98 |
|
|
2020
Q4 | $82.5M | Buy |
1,415,654
+191,724
| +16% | +$11.6M | 0.31% | 102 |
|
|
2020
Q3 | $77.3M | Buy |
1,223,930
+191,280
| +19% | +$13.3M | 0.36% | 92 |
|
|
2020
Q2 | $79.5M | Buy |
1,032,650
+137,440
| +15% | +$10.5M | 0.42% | 86 |
|
|
2020
Q1 | $66.9M | Sell |
895,210
-379,066
| -30% | -$26.2M | 0.48% | 76 |
|
|
2019
Q4 | $82.8M | Buy |
1,274,276
+113,236
| +10% | +$7.37M | 0.38% | 83 |
|
|
2019
Q3 | $73.6M | Buy |
1,161,040
+21,133
| +2% | +$1.38M | 0.41% | 81 |
|
|
2019
Q2 | $77M | Sell |
1,139,907
-164,587
| -13% | -$10.8M | 0.46% | 75 |
|
|
2019
Q1 | $84.8M | Buy |
1,304,494
+34,274
| +3% | +$2.28M | 0.51% | 59 |
|
|
2018
Q4 | $79.5M | Buy |
1,270,220
+154,322
| +14% | +$10.8M | 0.56% | 41 |
|
|
2018
Q3 | $86.2M | Sell |
1,115,898
-117,774
| -10% | -$8.89M | 0.58% | 32 |
|
|
2018
Q2 | $87.4M | Sell |
1,233,672
-81,803
| -6% | -$5.78M | 0.59% | 32 |
|
|
2018
Q1 | $99.2M | Buy |
1,315,475
+92,535
| +8% | +$7.36M | 0.65% | 26 |
|
|
2017
Q4 | $87.6M | Buy |
1,222,940
+256,850
| +27% | +$19.5M | 0.61% | 29 |
|
|
2017
Q3 | $78.3M | Buy |
966,090
+29,577
| +3% | +$2.26M | 0.72% | 25 |
|
|
2017
Q2 | $66.3M | Buy |
936,513
+85,540
| +10% | +$5.69M | 0.66% | 35 |
|
|
2017
Q1 | $57.8M | Sell |
850,973
-34,236
| -4% | -$2.41M | 0.6% | 56 |
|
|
2016
Q4 | $63.4M | Buy |
885,209
+150,701
| +21% | +$11.2M | 0.7% | 26 |
|
|
2016
Q3 | $58.1M | Sell |
734,508
-215,546
| -23% | -$17.5M | 0.81% | 22 |
|
|
2016
Q2 | $79.3M | Buy |
950,054
+20,433
| +2% | +$1.81M | 1.02% | 11 |
|
|
2016
Q1 | $85.4M | Sell |
929,621
-261,455
| -22% | -$23.6M | 1.18% | 8 |
|
|
2015
Q4 | $121M | Buy |
1,191,076
+52,407
| +5% | +$5.45M | 1.46% | 6 |
|
|
2015
Q3 | $112M | Buy |
1,138,669
+71,325
| +7% | +$7.92M | 1.57% | 4 |
|
|
2015
Q2 | $125M | Sell |
1,067,344
-198,987
| -16% | -$21.7M | 1.73% | 4 |
|
|
2015
Q1 | $124M | Buy |
1,266,331
+69,466
| +6% | +$7.05M | 1.46% | 4 |
|
|
2014
Q4 | $113M | Buy |
1,196,865
+334,169
| +39% | +$34.6M | 1.31% | 6 |
|
|
2014
Q3 | $91.8M | Sell |
862,696
-15,932
| -2% | -$1.56M | 1.22% | 6 |
|
|
2014
Q2 | $72.8M | Sell |
878,628
-159,019
| -15% | -$12.4M | 0.94% | 11 |
|
|
2014
Q1 | $73.5M | Buy |
1,037,647
+237,424
| +30% | +$18.6M | 0.92% | 8 |
|
|
2013
Q4 | $60.1M | Buy |
800,223
+305,087
| +62% | +$21.2M | 0.9% | 13 |
|
|
2013
Q3 | $31.1M | Sell |
495,136
-99,564
| -17% | -$5.95M | 0.74% | 15 |
|
|
2013
Q2 | $30.5M | Buy |
+594,700
| New | +$31M | 0.6% | 24 |
|
Other funds holding GILD
VCM
VPM
ProShare Advisors's GILD Position: Q1 2026 in Review
ProShare Advisors reduced its Gilead Sciences (GILD) stake by 18% in Q1 2026, selling an estimated $56.9M and leaving 1,811,223 shares worth $252M. The position accounts for 0.37% of the portfolio, ranked #31.
ProShare Advisors first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $272M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- ProShare Advisors held 1,811,223 shares of Gilead Sciences worth $252M as of Q1 2026.
- ProShare Advisors sold 406,067 Gilead Sciences shares in Q1 2026, an estimated $56.9M.
- Gilead Sciences made up 0.37% of ProShare Advisors's portfolio in Q1 2026, its #31 holding.
- ProShare Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Gilead Sciences position peaked at $272M in Q4 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.